Publication | Open Access

Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide

Hematological MalignancyOvarian TumourBreast Cancer PatientsMedicineMalignant Blood DisorderGynecologyPathologyBreast CancerMetronomic ChemotherapyCancer TreatmentOncologyGynecology OncologyOvarian Cancer